GLMD.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
symbol | last | change | %chng | name | mcap | sector | wiki | |
---|---|---|---|---|---|---|---|---|
GLMD | US | Galmed Pharmaceuticals Ltd |
Market global news for GLMD (US) Galmed Pharmaceuticals Ltd
Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
Galmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by StockNews.com tickerreport - 07:00 Mon 25 - GLMD - link story | |
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor prnewswire - 15:30 Thu 21 - GLMD - link story | |
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor marketscreener - 15:30 Thu 21 - GLMD - link story | |
Mira Pharma (MIRA) Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor streetinsider - 15:30 Thu 21 - GLMD - link story | |
Galmed Pharmaceutica Stock Quote | Stock Price for GLMD | FinancialContent Business Page financialcontent - 10:15 Sun 17 - GLMD - link story | |
Galmed Granted European Patent For Use Of Aramchol-Resmetirom To Treat NASH/MASH, Liver Fibrosis rttnews - 15:00 Fri 15 - GLMD - link story | |
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis lelezard - 14:45 Fri 15 - GLMD - link story | |
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis marketscreener - 13:30 Fri 15 - GLMD - link story | |
Galmed Pharmaceuticals (NASDAQ:GLMD) Earns Sell Rating from Analysts at StockNews.com wkrb13 - 09:00 Fri 23 - GLMD - link story |